Clinical Trials Logo

Filter by:
  • Available  
  • Page [1]
NCT ID: NCT04830202 Available - Clinical trials for Non-Small Cell Lung Cancer (NSCLC)

Expanded Access to Telisotuzumab Vedotin

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to Telisotuzumab vedotin prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.